Abstract:OBJECTIVE To reevaluate the bioequivalence of post-marketing metformin hydrochloride tablets.METHODS With the original metformin hydrochloride tablets(Glucophage) as the reference preparation,the in vitro dissolution of Glucophage and generic metformin hydrochloride tablets from eight pharmaceutical factories(A-H) was investigated using method 1 described in the appendix X C in Chinese Pharmacopoeia(edition 2010),among which two generic products were chosen for the bioequivalence study as test 1 and test 2 preparations.In a randomized,three-way crossover study,24 healthy male volunteers were given a single oral dose of test 1,test 2 and reference preparations containing 500 mg of metformin hydrochloride.Plasma concentrations of metformin were determined by LC-MS/MS.The pharmacokinetic parameters and relative bioavailability were calculated.The bioequivalence between test 1 and reference preparation,test 2 and reference preparation,and the bioequivalence between the two test preparations were evaluated.RESULTS The in vitro dissolution of the metformin hydrochloride tablets from all the nine factories met the standard of Chinese Pharmacopoeia(edition 2010).Metformin hydrochloride tablets from factory B and H,of which the cumulative dissolution rate-time profiles were significantly different from that of Glucophage,were chosen to be test 1 and test 2 preparations,respectively.The F0-t and F0-∞ were(102.0±13.3)% and(101.9±13.3)% for test 1 preparation,and(94.6±14.7)% and(94.4±14.5)% for test 2 preparation to Glucophage.Both test 1 and test 2 preparations were bioequivalent with reference preparation,and the two test preparations were also bioequivalent.CONCLUSION The bioinequivalence risk of metformin hydrochloride tablets is low.Biowaivers can be granted for generic metformin hydrochloride tablets on the basis of in vitro dissolution evaluation,to save cost,improve efficiency in drug development and supervision,and reduce unnecessary drug exposure in human body.

Investigation on the Dissolution Rates of Glibenclamide and Metformin in Compound Metformin Hydrochloride

Study of bioequivalence of compound metformin hydrochloride tablet in healthy volunteers

Determination of Metformin Hydrochloride and Glibenclamide Using HPLC and LC-MS

Relative bioavailability of compound metformin hydrochloride tablets in healthy volunteers

Pharmacokinetics and bioequivalance of domestic compound glibenclamide and metformin in chinese healthy volunteers

A consistency evaluation based on Chinese literatures for generic metformin hydrochloride

Pharmacokinetic and Bioequivalence Studies of 2 Metformin Glibenclamide Tablets in Healthy Chinese Subjects Under Fasting and Fed Conditions

Study on the relative bioavailability of metformin hydrochloride sustained-release tablets

Pharmacokinetics and Bioequivalence of Compound Mefformin Hydrochloride Tablets in Healthy Volunteers

Determination and Correlation of Solubility of Metformin Hydrochloride in Aqueous Binary Solvents from 283.15 to 323.15 K

Pharmacokinetics and relative bioavailability of compound metformin hydrochloride tablet in healthy volunteers

Study of Hot Melt Granulation to Improve Dissolution Rate of Empagliflozin

Post-Marketing Reevaluation on Bioequivalence of Metformin Hydrochloride Tablets

Study on the Dissolution of Compound Tramadol Hydrochloride Tablets

Solubility Measurement and Data Correlation of Metformin Hydrochloride in Four Aqueous Binary Solvents and Three Pure Solvents from 283.15 to 323.15 K

Preparation and in vitro Dissolution of Gliclazide Sustained-release Tablets

Preparation and in Vivo/in Vitro Evaluation of Gimepiride,Pioglitazone and Metformin Sustained-Release Tablets

Questions in the Bioequivalence Tests of the Preparations Containing Metformin Hydrochloride

A Simple and Sensitive HPTLC Method for Simultaneous Determination of Metformin Hydrochloride and Sitagliptin Phosphate in Tablet Dosage Form

Comparison of Dissolution Rates in Vitro of Maxingshigan Dropping Pill and Suppository

Determination of Plasma-Drug Concentration of Metformin Hydrochloride by RP-HPLC